Podcast Episodes
Back to SearchCirculation:January 6, 2026 Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial
The STORM-PE clinical trial investigated whether using a computer-assisted vacuum thrombectomy device to physically remove blood clots provides bette…
9 months, 1 week ago
Circulation:January 6, 2026 Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial
The CAVIAR trial investigated whether adding the drug alirocumab to standard statin therapy could prevent artery disease in heart transplant recipien…
9 months, 1 week ago
THE LANCET: December 31, 2025:International trends and social disparities in pain of adults aged 50 years and older in 22 countries across Europe, Asia, and the Americas: a longitudinal population-based study
This longitudinal study examines how chronic physical suffering evolved over two decades among aging populations across twenty-two different nations.…
9 months, 1 week ago
THE LANCET Volume 407, Issue 10523P31-52January 03, 2026 Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
This comprehensive analysis examines the staggering global impact of domestic and childhood abuse on public health, revealing that over a billion peo…
9 months, 1 week ago
N Engl J Med 2026;394:51-61 Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab
patients suffering from a particularly aggressive form of cancer known as true extramedullary myeloma. By simultaneously attacking two different mark…
9 months, 1 week ago
NEJM: Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC
This clinical study investigates whether combining the targeted drug osimertinib with traditional chemotherapy offers a superior outcome for patients…
9 months, 1 week ago
N Engl J Med 2026;394:13-26 Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC
This study evaluates the effectiveness of sacituzumab tirumotecan, a novel antibody-drug conjugate, for patients with advanced lung cancer whose dise…
9 months, 1 week ago
Most Popular Articles JAMA 2025 Episode 2:Screening for Osteoporosis to Prevent Fractures US Preventive Services Task Force Recommendation Statement
This clinical guideline establishes a framework for using medical screenings to identify bone density loss before it leads to debilitating injuries. …
9 months, 2 weeks ago
Most Popular Articles JAMA 2025 Episode 1:The DECAF Trial
The DECAF Trial challenged the long-held medical assumption that caffeine triggers irregular heart rhythms by investigating its actual impact on pati…
9 months, 2 weeks ago
The Lancet December 2025:Neurobehavioural links from infant screen time to anxiety
This research explores how early exposure to digital media impacts the long-term mental health of children by tracing a specific neurodevelopmental p…
9 months, 2 weeks ago